Briggs P C, Heckler F R
Division of Plastic Surgery, Allegheny General Hospital, Pittsburgh, Pa.
Plast Reconstr Surg. 1988 Jun;81(6):952-3.
We present a patient with a Clark level IV melanoma who received BCG immunotherapy by scarification for 12 months after wide excision. Six months after cessation of treatment, the patient developed regional lymphadenopathy that histology showed to be reactive epithelioid granuloma. Regional immunotherapy thus represents a potentially confusing factor in the post-operative assessment and management of the patient with melanoma.
我们报告一例患有克拉克四级黑色素瘤的患者，该患者在广泛切除术后通过划痕法接受了12个月的卡介苗免疫治疗。治疗停止6个月后，患者出现区域淋巴结病，组织学检查显示为反应性上皮样肉芽肿。因此，区域免疫治疗在黑色素瘤患者的术后评估和管理中可能是一个容易混淆的因素。
